Cha AI Healthcare Co., Ltd. (KRX:025620)

Market Cap	222.14B +1,201.4%
Revenue (ttm)	7.84B -57.5%
Net Income	-6.96B
EPS	-1,241.14
Shares Out	18.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	206,863
Average Volume	159,774
Open	12,550
Previous Close	12,730
Day's Range	11,990 - 13,460
52-Week Range	3,320 - 19,780
Beta	-2.01
RSI	59.25
Earnings Date	Mar 20, 2026

About Cha AI Healthcare

Cha AI Healthcare Co., Ltd., together with its subsidiaries, manufactures and distributes cosmetic products in South Korea. The company offers facial care products, including masks/packs, skin/toner/mist, pads/patches, ampoules/serums/essence, lotion/emulsion, creams/gels, cleansing/peeling, sun care, and beauty accessories products; skin cells/texture, moisture/moisturizing, whitening/brightening, and sensitive/calm care products; nutritional/elasticity/anti-aging care products; and UV protection care products. The company was formerly known a...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1972
• Employees: 44
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 025620

Financial Performance

In 2024, Cha AI Healthcare's revenue was 15.68 billion, a decrease of -2.57% compared to the previous year's 16.09 billion. Losses were -9.49 billion, 39.7% more than in 2023.